There have been studies demonstrating increased MT1 expression in neurodegenerative conditions such as Parkinson’s and Alzheimer’s Diseases, where it is proposed to be neuroprotective [54,55,56], but none examining the contributions of MT1 expression in CNS cells to the pathogenesis of HIV-NCI. Here, MT1X is linked to Parkinson disease.